Relafen or Naproxen 750, viewed analyzed from a biochemical molecular pharmacy perspective, represents a compelling significant illustration of NSAID or non-copyrightal anti-inflammatory drug action. Its mechanism approach involves primarily or mainly inhibiting cyclooxygenase enzymes, specifically COX-2, thereby reducing diminishing the production